How Does Retatrutide (GLP-3) Work? Mechanism of Action Explained

Direct Answer

Retatrutide works by simultaneously activating three separate hormone receptors, GLP-1, GIP, and glucagon, in a single molecule. Each receptor contributes a distinct effect: GLP-1 activation slows digestion and reduces appetite, GIP activation is believed to enhance insulin sensitivity and may improve gastrointestinal tolerability, and glucagon activation increases energy expenditure and fat oxidation, an effect not present in single- or dual-agonist medications.

Why Three Receptors Instead of One or Two

Semaglutide activates only the GLP-1 receptor. Tirzepatide activates GLP-1 and GIP. Retatrutide adds a third target, the glucagon receptor, which is genuinely novel among GLP-1-class medications. Glucagon's role is different from the other two, rather than primarily suppressing appetite, it pushes the body to burn more energy and process fat more efficiently, a genuinely additive mechanism rather than a stronger version of the same effect.

The Liver Connection

Glucagon receptor activation is specifically associated with meaningful liver fat reduction in trial data, which is part of why retatrutide is also being studied for metabolic dysfunction-associated steatohepatitis (MASH), a use case single-target GLP-1 medications don't address as directly.

Bottom Line

Retatrutide's three-receptor mechanism is genuinely mechanistically distinct from earlier GLP-1 medications, not simply a higher dose of the same effect, combining appetite suppression, improved metabolic function, and increased energy expenditure into one medication.

References

• Coskun T, et al. LY3437943, A Novel Triple GIP, GLP-1, and Glucagon Receptor Agonist. Cell Metabolism (2022)

Related Resources

• Retatrutide Medication Guide
• What Is "GLP-3"? The Truth Behind This Trending Term

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Track retatrutide alongside every other GLP-1 medication on DietApp.com.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. Retatrutide is investigational and not FDA-approved. This article is for general informational purposes and is not medical advice.